| Health / Medical Topics |
Cabergoline
A synthetic ergoline derivative and a long-acting dopamine receptor agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an inhibitory effect on prolactin secretion by acting on dopamine receptors present in pituitary lactotrophs. This drug also binds to dopamine D2 receptors in the corpus striatum, thereby mimicking the actions of dopamine on motor control. Cabergoline also possesses antioxidant and neuroprotective properties due to its free radical scavenging activity. Cabergoline is used in the treatment of Parkinson's disease and in the treatment of hyperprolactinemia. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used with prednisone to treat hormone-resistant prostate cancer that has spread and that had been treated with docetaxel. It is…
In medicine, a group of non-scientist volunteers that serves as a link between a community and clinical trial researchers. A CAB may…
An NCICB informatics project consisting of a microarray database and microarray data analysis and visualization tools.
Human CA9 wild-type allele is located in the vicinity of 9p13.3 and is approximately 7 kb in length. This allele, which encodes…
This gene may be involved in cell proliferation and transformation.
The last of four regions in the cornu ammonis of the hippocampus and is also part of the hilus of the dentate…
